Franklin Biotechnology Discovery Fund Price Prediction
| FBDIX Fund | USD 139.62 2.21 1.56% |
Oversold Vs Overbought
26
Oversold | Overbought |
Using Franklin Biotechnology hype-based prediction, you can estimate the value of Franklin Biotechnology Discovery from the perspective of Franklin Biotechnology response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in Franklin Biotechnology to buy its mutual fund at a price that has no basis in reality. In that case, they are not buying Franklin because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell mutual funds at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Franklin Biotechnology after-hype prediction price | USD 141.86 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as fund price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Franklin |
Franklin Biotechnology After-Hype Price Prediction Density Analysis
As far as predicting the price of Franklin Biotechnology at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Franklin Biotechnology or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Mutual Fund prices, such as prices of Franklin Biotechnology, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Franklin Biotechnology Estimiated After-Hype Price Volatility
In the context of predicting Franklin Biotechnology's mutual fund value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Franklin Biotechnology's historical news coverage. Franklin Biotechnology's after-hype downside and upside margins for the prediction period are 140.67 and 143.05, respectively. We have considered Franklin Biotechnology's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Franklin Biotechnology is very steady at this time. Analysis and calculation of next after-hype price of Franklin Biotechnology is based on 3 months time horizon.
Franklin Biotechnology Mutual Fund Price Prediction Analysis
Have you ever been surprised when a price of a Mutual Fund such as Franklin Biotechnology is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Franklin Biotechnology backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Fund price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Franklin Biotechnology, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.07 | 1.22 | 0.04 | 0.00 | 1 Events / Month | 0 Events / Month | Very soon |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
139.62 | 141.86 | 0.02 |
|
Franklin Biotechnology Hype Timeline
Franklin Biotechnology is currently traded for 139.62. The entity has historical hype elasticity of 0.04, and average elasticity to hype of competition of 0.0. Franklin is forecasted to increase in value after the next headline, with the price projected to jump to 141.86 or above. The average volatility of media hype impact on the company the price is over 100%. The price jump on the next news is projected to be 0.02%, whereas the daily expected return is currently at -0.07%. The volatility of related hype on Franklin Biotechnology is about 0.0%, with the expected price after the next announcement by competition of 139.62. Assuming the 90 days horizon the next forecasted press release will be very soon. Check out Franklin Biotechnology Basic Forecasting Models to cross-verify your projections.Franklin Biotechnology Related Hype Analysis
Having access to credible news sources related to Franklin Biotechnology's direct competition is more important than ever and may enhance your ability to predict Franklin Biotechnology's future price movements. Getting to know how Franklin Biotechnology's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Franklin Biotechnology may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| LTXFX | Limited Term Tax | 0.00 | 0 per month | 0.11 | (0.69) | 0.20 | (0.19) | 0.78 | |
| GTLSX | Quantitative Longshort Equity | 0.00 | 0 per month | 0.21 | (0.12) | 0.71 | (0.50) | 2.57 | |
| PRMDX | Maryland Short Term Tax Free | 0.00 | 0 per month | 0.01 | (1.05) | 0.20 | (0.19) | 0.59 | |
| BXDCX | Barings Active Short | 0.00 | 0 per month | 0.00 | (0.75) | 0.22 | (0.11) | 0.65 | |
| RSDIX | Rbc Short Duration | 0.00 | 0 per month | 0.00 | (0.83) | 0.21 | (0.10) | 0.72 | |
| LCSAX | Locorr Longshort Modities | 0.00 | 0 per month | 0.00 | (0.50) | 0.33 | (0.54) | 1.37 | |
| FSILX | Federated Short Term Income | 0.00 | 0 per month | 0.00 | (0.74) | 0.24 | (0.12) | 0.83 | |
| ASCLX | Ab Select Longshort | 0.00 | 0 per month | 0.38 | (0.08) | 0.77 | (0.93) | 2.91 |
Franklin Biotechnology Additional Predictive Modules
Most predictive techniques to examine Franklin price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Franklin using various technical indicators. When you analyze Franklin charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Franklin Biotechnology Predictive Indicators
The successful prediction of Franklin Biotechnology stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Franklin Biotechnology Discovery, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Franklin Biotechnology based on analysis of Franklin Biotechnology hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Franklin Biotechnology's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Franklin Biotechnology's related companies.
Story Coverage note for Franklin Biotechnology
The number of cover stories for Franklin Biotechnology depends on current market conditions and Franklin Biotechnology's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Franklin Biotechnology is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Franklin Biotechnology's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Other Macroaxis Stories
Our audience includes start-ups and big corporations as well as marketing, public relation firms, and advertising agencies, including technology and finance journalists. Our platform and its news and story outlet are popular among finance students, amateur traders, self-guided investors, entrepreneurs, retirees and baby boomers, academic researchers, financial advisers, as well as professional money managers - a very diverse and influential demographic landscape united by one goal - build optimal investment portfolios
Story Categories
Currently Trending Categories
Other Information on Investing in Franklin Mutual Fund
Franklin Biotechnology financial ratios help investors to determine whether Franklin Mutual Fund is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Franklin with respect to the benefits of owning Franklin Biotechnology security.
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope |